Effect of Hypnosis in the Management of Anxiety and Chemo-induced Symptoms in Adolescents and Young Adults With Sarcoma or Germ Cell Tumor and in Young Women With Breast Cancer

Shown exactly as written on ClinicalTrials.gov. Your oncologist is the right person to judge whether it fits your situation.

Inclusion Criteria:

1. Newly diagnosed patients receiving initial care and follow-up at the Institut Bergonié during treatment:

   1. Adolescents or young adults (AJA) aged 15 to 39 with soft tissue or bone sarcoma or a germ cell tumor (testicular, ovarian),
   2. Young women aged 15 to 49 with breast cancer.
2. Treatment with neoadjuvant chemotherapy based on anthracyclines and/or alkylating agents.
3. Treatment administered as:

   1. Inpatient for patients with soft tissue or bone sarcoma or a germ cell tumor (testicular, ovarian),
   2. Outpatient or day hospital for female patients with breast cancer.
4. Dated and signed informed consent (if the patient is a minor, consent must also be signed by the legal guardians).
5. Patient enrolled in a social security program in accordance with current regulations.

Exclusion Criteria:

1. Known contraindications to hypnosis (psychotic disorders, mental disorders, confusion, deafness, severe cognitive impairment, etc.)
2. Patients who have already undergone hypnosis sessions within 6 months prior to enrollment.
3. Geographic, social, or psychological factors rendering the patient unable to comply with the study's follow-up and procedures.
4. Patients who are deprived of their liberty or subject to a legal protection measure (guardianship, conservatorship, judicial protection, or family authorization).